Clinical Trials on DSM-5 Schizophrenia in Japan
Total 64 results
-
Otsuka Pharmaceutical Co., Ltd.Otsuka Pharmaceutical Development & Commercialization, Inc.RecruitingAcute SchizophreniaJapan
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Chiba UniversityCompleted
-
Sumitomo Pharma Co., Ltd.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Otsuka Pharmaceutical Co., Ltd.Recruiting
-
Otsuka Pharmaceutical Co., Ltd.Recruiting
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Yokohama City UniversityCompleted
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Eli Lilly and CompanyCompleted
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Hamamatsu UniversitySuspendedSchizophrenia | Negative Symptoms | Cognitive ImpairmentsJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedSchizophreniaTaiwan, Korea, Republic of, Japan
-
NovartisCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedSchizophreniaTaiwan, Korea, Republic of, Japan
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Sumitomo Pharma Co., Ltd.CompletedSchizophreniaJapan, Korea, Republic of, Taiwan
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Sumitomo Pharma Co., Ltd.CompletedSchizophreniaJapan, Korea, Republic of, Malaysia, Taiwan
-
Sumitomo Pharma Co., Ltd.CompletedSchizophreniaJapan, Korea, Republic of, Malaysia, Taiwan
-
Sumitomo Pharma Co., Ltd.Completed
-
Otsuka Pharmaceutical Co., Ltd.CompletedSchizophreniaJapan
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Eli Lilly and CompanyCompleted
-
Osaka UniversityActive, not recruitingChronic Kidney Disease Stage 5Japan
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompleted
-
Sumitomo Pharma Co., Ltd.Completed
-
Sumitomo Pharma Co., Ltd.CompletedSchizophreniaChina, Japan, Korea, Republic of, Malaysia, Philippines, Russian Federation, Taiwan, Ukraine
-
Denovo Biopharma LLCTerminated
-
Janssen Pharmaceutical K.K.Completed
-
H. Lundbeck A/STerminatedTreatment-resistant SchizophreniaUnited States, Japan, Russian Federation, Bulgaria, United Kingdom
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAcute SchizophreniaKorea, Republic of, United States, Serbia, Ukraine, Romania, Poland, Canada, Latvia, Japan
-
Hoffmann-La RocheCompletedSchizophrenia, Schizoaffective DisorderUnited States, Japan, Ukraine, Russian Federation
-
Janssen Pharmaceutical K.K.CompletedSchizophreniaTaiwan, Japan, Korea, Republic of
-
Hoffmann-La RocheTerminatedSchizophrenia, Schizoaffective DisorderUnited States, Spain, Japan, Ukraine
-
Janssen Pharmaceutical K.K.Completed
-
Sumitomo Pharma Co., Ltd.TerminatedSchizophreniaJapan, Taiwan, China, Philippines
-
Boehringer IngelheimCompletedSchizophreniaUnited States, Taiwan, Germany, Japan, Canada
-
Sumitomo Pharma Co., Ltd.Terminated
-
Hoffmann-La RocheCompletedSchizophreniaUnited States, Poland, Hungary, Russian Federation, Germany, Austria, France, Brazil, Japan, Mexico
-
Boehringer IngelheimTerminatedSchizophreniaUnited States, Korea, Republic of, Canada, Japan, Spain, Taiwan, France
-
BiogenCompletedCognitive Impairment Associated With SchizophreniaSpain, United States, Germany, Japan, United Kingdom
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaKorea, Republic of, United States, Philippines, Malaysia, Croatia, Serbia, Russian Federation, Ukraine, Romania, Puerto Rico, Colombia, Turkey, Poland, Taiwan, Canada, Latvia, Slovakia, Mexico, Japan
-
AbbVieActive, not recruiting